MGX · Metagenomi Therapeutics, Inc. · Documents
Market Cap
$30.67M
Shares
37.78M
Volume · Oct 20
19.09K
Avg daily vol (3M)
157.61K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2026-09-22 | 2026-09-21 | |
| 10-Q | — | 2026-08-10 | 2026-06-30 | |
| 8-K | — | 2026-08-10 | — | |
| 8-K | — | 2026-06-10 | 2026-06-09 | |
| 10-Q | — | 2026-05-11 | 2026-03-31 | |
| 8-K | — | 2026-05-11 | — | |
| DEF 14A | — | 2026-04-27 | 2026-04-21 | |
| 8-K | — | 2026-03-05 | — | |
| 10-K | — | 2026-03-05 | 2025-12-31 | |
| 8-K | — | 2026-01-12 | — | |
| 10-Q | — | 2025-11-12 | 2025-09-30 | |
| 8-K | — | 2025-11-12 | 2025-11-11 | |
| 8-K | — | 2025-10-01 | 2025-09-29 | |
| 8-K | — | 2025-08-12 | — | |
| 10-Q | — | 2025-08-12 | 2025-06-30 | |
| 8-K | — | 2025-06-11 | 2025-06-10 | |
| 8-K | — | 2025-05-14 | — | |
| 10-Q | — | 2025-05-13 | 2025-03-31 | |
| 8-K | — | 2025-05-13 | — | |
| DEF 14A | — | 2025-04-28 | 2025-04-25 | |
| 10-K | — | 2025-03-17 | 2024-12-31 | |
| 8-K | — | 2025-03-17 | — | |
| 8-K | — | 2025-03-17 | — | |
| 8-K | — | 2025-01-16 | 2025-01-13 | |
| 8-K | — | 2024-12-10 | 2024-12-09 | |
| 8-K | — | 2024-11-13 | — | |
| 10-Q | — | 2024-11-13 | 2024-09-30 | |
| 8-K | — | 2024-09-03 | — | |
| 10-Q | — | 2024-08-14 | 2024-06-30 | |
| 8-K | — | 2024-08-14 | — | |
| 10-Q | — | 2024-05-14 | 2024-03-31 | |
| 8-K | — | 2024-05-14 | — | |
| 8-K | — | 2024-05-01 | 2024-04-26 | |
| 10-K | — | 2024-03-27 | 2023-12-31 | |
| 8-K | — | 2024-03-27 | — | |
| 8-K | — | 2024-02-13 | — |
Showing 1–36 of 36 filings